Teladoc Health, Inc. (NYSE: TDOC) Stock Competitors & Peer Comparison

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, VEEV has a market cap of 30.7B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while VEEV trades at $189.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas VEEV's P/E ratio is 22.71. In terms of profitability, TDOC's ROE is -0.12%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, TDOC is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check VEEV's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, GEHC has a market cap of 28.2B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while GEHC trades at $62.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas GEHC's P/E ratio is 13.61. In terms of profitability, TDOC's ROE is -0.12%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, TDOC is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check GEHC's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while GEHCV trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas GEHCV's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, TDOC is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check GEHCV's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, BTSGU has a market cap of 14.4B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while BTSGU trades at $239.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas BTSGU's P/E ratio is 216.59. In terms of profitability, TDOC's ROE is -0.12%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check BTSGU's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, BTSG has a market cap of 14.2B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while BTSG trades at $72.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas BTSG's P/E ratio is 58.52. In terms of profitability, TDOC's ROE is -0.12%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check BTSG's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SGFY trades at $30.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SGFY's P/E ratio is 70.91. In terms of profitability, TDOC's ROE is -0.12%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, TDOC is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SGFY's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, TEM has a market cap of 8.5B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while TEM trades at $48.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas TEM's P/E ratio is -97.96. In terms of profitability, TDOC's ROE is -0.12%, compared to TEM's ROE of -0.70%. Regarding short-term risk, TDOC is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check TEM's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, HQY has a market cap of 8.2B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while HQY trades at $97.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas HQY's P/E ratio is 22.84. In terms of profitability, TDOC's ROE is -0.12%, compared to HQY's ROE of +0.11%. Regarding short-term risk, TDOC is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check HQY's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, HNGE has a market cap of 6.5B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while HNGE trades at $84.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas HNGE's P/E ratio is 43.22. In terms of profitability, TDOC's ROE is -0.12%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, TDOC is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HNGE's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while RCM trades at $14.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas RCM's P/E ratio is -102.21. In terms of profitability, TDOC's ROE is -0.12%, compared to RCM's ROE of +0.00%. Regarding short-term risk, TDOC is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check RCM's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, TXG has a market cap of 6B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while TXG trades at $47.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas TXG's P/E ratio is -277.65. In terms of profitability, TDOC's ROE is -0.12%, compared to TXG's ROE of -0.03%. Regarding short-term risk, TDOC is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check TXG's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, DOCS has a market cap of 3.9B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while DOCS trades at $21.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas DOCS's P/E ratio is 13.79. In terms of profitability, TDOC's ROE is -0.12%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, TDOC is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check DOCS's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ONEM trades at $16.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ONEM's P/E ratio is -7.77. In terms of profitability, TDOC's ROE is -0.12%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, TDOC is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check ONEM's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, PRVA has a market cap of 3.3B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while PRVA trades at $26.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas PRVA's P/E ratio is 164.44. In terms of profitability, TDOC's ROE is -0.12%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, TDOC is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check PRVA's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while PGNY trades at $32.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas PGNY's P/E ratio is 23.53. In terms of profitability, TDOC's ROE is -0.12%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, TDOC is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check PGNY's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while HTFL trades at $25.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas HTFL's P/E ratio is -12.66. In terms of profitability, TDOC's ROE is -0.12%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, TDOC is less volatile compared to HTFL. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HTFL's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while WGS trades at $61.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas WGS's P/E ratio is 72.53. In terms of profitability, TDOC's ROE is -0.12%, compared to WGS's ROE of -0.28%. Regarding short-term risk, TDOC is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check WGS's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while NXGN trades at $23.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas NXGN's P/E ratio is -266.00. In terms of profitability, TDOC's ROE is -0.12%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, TDOC is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check NXGN's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while AGTI trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas AGTI's P/E ratio is -71.79. In terms of profitability, TDOC's ROE is -0.12%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, TDOC is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AGTI's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while OMDA trades at $22.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas OMDA's P/E ratio is 328.43. In terms of profitability, TDOC's ROE is -0.12%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, TDOC is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check OMDA's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CERT trades at $6.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CERT's P/E ratio is 17.56. In terms of profitability, TDOC's ROE is -0.12%, compared to CERT's ROE of -0.01%. Regarding short-term risk, TDOC is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CERT's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, GDRX has a market cap of 1B. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while GDRX trades at $3.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas GDRX's P/E ratio is 9.15. In terms of profitability, TDOC's ROE is -0.12%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, TDOC is less volatile compared to GDRX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check GDRX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CCLDO trades at $27.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CCLDO's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CCLDO's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, HSTM has a market cap of 813.4M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while HSTM trades at $27.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas HSTM's P/E ratio is 36.63. In terms of profitability, TDOC's ROE is -0.12%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, TDOC is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check HSTM's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, EVH has a market cap of 656.9M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while EVH trades at $5.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas EVH's P/E ratio is 584.00. In terms of profitability, TDOC's ROE is -0.12%, compared to EVH's ROE of -0.78%. Regarding short-term risk, TDOC is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check EVH's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, PHR has a market cap of 654.6M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while PHR trades at $10.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas PHR's P/E ratio is 37.82. In terms of profitability, TDOC's ROE is -0.12%, compared to PHR's ROE of +0.03%. Regarding short-term risk, TDOC is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check PHR's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while MPLN-WT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, TDOC is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MPLN-WT's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ACCD trades at $7.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ACCD's P/E ratio is -3.08. In terms of profitability, TDOC's ROE is -0.12%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, TDOC is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check ACCD's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SHCR trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SHCR's P/E ratio is -3.76. In terms of profitability, TDOC's ROE is -0.12%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, TDOC is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SHCR's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, WGSWW has a market cap of 514.5M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while WGSWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas WGSWW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, TDOC is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check WGSWW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CTEV has a market cap of 488.4M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CTEV trades at $28.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CTEV's P/E ratio is -2.20. In terms of profitability, TDOC's ROE is -0.12%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, TDOC is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check CTEV's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, NRC has a market cap of 484.1M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while NRC trades at $21.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas NRC's P/E ratio is 26.20. In terms of profitability, TDOC's ROE is -0.12%, compared to NRC's ROE of +0.57%. Regarding short-term risk, TDOC is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check NRC's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SOPH has a market cap of 446.8M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SOPH trades at $6.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SOPH's P/E ratio is -12.50. In terms of profitability, TDOC's ROE is -0.12%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, TDOC is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SOPH's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SLGC trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SLGC's P/E ratio is -3.04. In terms of profitability, TDOC's ROE is -0.12%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, TDOC is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SLGC's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SLGCW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, TDOC's ROE is -0.12%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, TDOC is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SLGCW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while TBRG trades at $26.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas TBRG's P/E ratio is 9.37. In terms of profitability, TDOC's ROE is -0.12%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, TDOC is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check TBRG's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while MPLN trades at $23.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas MPLN's P/E ratio is -0.23. In terms of profitability, TDOC's ROE is -0.12%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, TDOC is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MPLN's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SLP trades at $18.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SLP's P/E ratio is 20.72. In terms of profitability, TDOC's ROE is -0.12%, compared to SLP's ROE of +0.06%. Regarding short-term risk, TDOC is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SLP's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while TRHC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas TRHC's P/E ratio is -4.27. In terms of profitability, TDOC's ROE is -0.12%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, TDOC is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check TRHC's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SMFR trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SMFR's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, TDOC is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SMFR's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SY has a market cap of 240.1M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SY trades at $1.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SY's P/E ratio is -5.55. In terms of profitability, TDOC's ROE is -0.12%, compared to SY's ROE of -0.16%. Regarding short-term risk, TDOC is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SY's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SPOK has a market cap of 222.7M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SPOK trades at $10.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SPOK's P/E ratio is 17.77. In terms of profitability, TDOC's ROE is -0.12%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, TDOC is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SPOK's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, AMWL has a market cap of 209M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while AMWL trades at $12.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas AMWL's P/E ratio is -2.41. In terms of profitability, TDOC's ROE is -0.12%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, TDOC is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check AMWL's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, HCAT has a market cap of 159.6M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while HCAT trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas HCAT's P/E ratio is 10.80. In terms of profitability, TDOC's ROE is -0.12%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, TDOC is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HCAT's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CPSI trades at $9.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CPSI's P/E ratio is -183.80. In terms of profitability, TDOC's ROE is -0.12%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, TDOC is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check CPSI's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, OPRX has a market cap of 125M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while OPRX trades at $6.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas OPRX's P/E ratio is 6.11. In terms of profitability, TDOC's ROE is -0.12%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, TDOC is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check OPRX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while AUGX trades at $2.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas AUGX's P/E ratio is -4.99. In terms of profitability, TDOC's ROE is -0.12%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, TDOC is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AUGX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CCLD has a market cap of 94.8M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CCLD trades at $2.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CCLD's P/E ratio is 8.26. In terms of profitability, TDOC's ROE is -0.12%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CCLD's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, DH has a market cap of 76.5M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while DH trades at $0.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas DH's P/E ratio is 2.79. In terms of profitability, TDOC's ROE is -0.12%, compared to DH's ROE of -0.67%. Regarding short-term risk, TDOC is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check DH's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while FORA trades at $2.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas FORA's P/E ratio is -24.11. In terms of profitability, TDOC's ROE is -0.12%, compared to FORA's ROE of -0.17%. Regarding short-term risk, TDOC is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check FORA's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CCLDP trades at $19.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CCLDP's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CCLDP's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ONMD has a market cap of 37.2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ONMD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ONMD's P/E ratio is -4.36. In terms of profitability, TDOC's ROE is -0.12%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, TDOC is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ONMD's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SNCE trades at $5.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SNCE's P/E ratio is -0.27. In terms of profitability, TDOC's ROE is -0.12%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, TDOC is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SNCE's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while AKLI trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas AKLI's P/E ratio is -0.71. In terms of profitability, TDOC's ROE is -0.12%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, TDOC is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AKLI's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SHLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SHLT's P/E ratio is -3.87. In terms of profitability, TDOC's ROE is -0.12%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, TDOC is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check SHLT's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ONMDW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ONMDW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, TDOC is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check ONMDW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SHCRW trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.12%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, TDOC is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SHCRW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, EUDA has a market cap of 26.8M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while EUDA trades at $15.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas EUDA's P/E ratio is -27.08. In terms of profitability, TDOC's ROE is -0.12%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, TDOC is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check EUDA's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while STRM trades at $5.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas STRM's P/E ratio is -2.40. In terms of profitability, TDOC's ROE is -0.12%, compared to STRM's ROE of -0.32%. Regarding short-term risk, TDOC is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check STRM's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while RNLX trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas RNLX's P/E ratio is -0.33. In terms of profitability, TDOC's ROE is -0.12%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, TDOC is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check RNLX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while LIFW trades at $3.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas LIFW's P/E ratio is -0.02. In terms of profitability, TDOC's ROE is -0.12%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, TDOC is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check LIFW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, BEATW has a market cap of 18M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while BEATW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas BEATW's P/E ratio is -0.05. In terms of profitability, TDOC's ROE is -0.12%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, TDOC is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check BEATW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while BBLN trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas BBLN's P/E ratio is -0.04. In terms of profitability, TDOC's ROE is -0.12%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, TDOC is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check BBLN's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ETAO trades at $1.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ETAO's P/E ratio is -0.01. In terms of profitability, TDOC's ROE is -0.12%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, TDOC is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ETAO's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while BFRG trades at $0.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas BFRG's P/E ratio is -1.19. In terms of profitability, TDOC's ROE is -0.12%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, TDOC is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check BFRG's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, SCNX has a market cap of 6M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while SCNX trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas SCNX's P/E ratio is -0.15. In terms of profitability, TDOC's ROE is -0.12%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, TDOC is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check SCNX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while UPH trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas UPH's P/E ratio is -0.07. In terms of profitability, TDOC's ROE is -0.12%, compared to UPH's ROE of -1.05%. Regarding short-term risk, TDOC is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check UPH's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while UPH-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, TDOC is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check UPH-WT's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, MGRX has a market cap of 4.8M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while MGRX trades at $0.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas MGRX's P/E ratio is -0.35. In terms of profitability, TDOC's ROE is -0.12%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, TDOC is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MGRX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while PEAR trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas PEAR's P/E ratio is -0.08. In terms of profitability, TDOC's ROE is -0.12%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, TDOC is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check PEAR's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while PEARW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas PEARW's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.12%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, TDOC is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check PEARW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while OTRK trades at $0.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas OTRK's P/E ratio is -0.02. In terms of profitability, TDOC's ROE is -0.12%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, TDOC is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check OTRK's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while HCTI trades at $1.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas HCTI's P/E ratio is -0.22. In terms of profitability, TDOC's ROE is -0.12%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, TDOC is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check HCTI's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CMAX trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CMAX's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.12%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, TDOC is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CMAX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while VSEE trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas VSEE's P/E ratio is -0.17. In terms of profitability, TDOC's ROE is -0.12%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, TDOC is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check VSEE's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ACON trades at $2.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ACON's P/E ratio is -0.24. In terms of profitability, TDOC's ROE is -0.12%, compared to ACON's ROE of -0.54%. Regarding short-term risk, TDOC is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check ACON's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while LIFWZ trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, TDOC is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check LIFWZ's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, VSEEW has a market cap of 1.2M. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while VSEEW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, TDOC's ROE is -0.12%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, TDOC is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check VSEEW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while EUDAW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, TDOC's ROE is -0.12%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, TDOC is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check EUDAW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, WORX has a market cap of 602.8K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while WORX trades at $0.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas WORX's P/E ratio is -0.66. In terms of profitability, TDOC's ROE is -0.12%, compared to WORX's ROE of -0.65%. Regarding short-term risk, TDOC is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check WORX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while MSPRZ trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, TDOC is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MSPRZ's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while KERN trades at $0.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas KERN's P/E ratio is -0.01. In terms of profitability, TDOC's ROE is -0.12%, compared to KERN's ROE of -0.17%. Regarding short-term risk, TDOC is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check KERN's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while KERNW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas KERNW's P/E ratio is -0.00. In terms of profitability, TDOC's ROE is -0.12%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, TDOC is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check KERNW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while LIFWW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas LIFWW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, TDOC is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check LIFWW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ZCMD has a market cap of 51.1K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ZCMD trades at $1.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, TDOC's ROE is -0.12%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, TDOC is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ZCMD's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CMAXW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CMAXW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, TDOC is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CMAXW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, ACONW has a market cap of 11.2K. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while ACONW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas ACONW's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, TDOC is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check ACONW's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while MTBCO trades at $25.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas MTBCO's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check MTBCO's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while AFFX trades at $14.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas AFFX's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, TDOC is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check AFFX's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while MTBCP trades at $26.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas MTBCP's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, TDOC is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check MTBCP's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while MTBC trades at $3.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas MTBC's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, TDOC is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check MTBC's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CHNG trades at $27.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CHNG's P/E ratio is -152.72. In terms of profitability, TDOC's ROE is -0.12%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, TDOC is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CHNG's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CHNGU trades at $73.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CHNGU's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, TDOC is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CHNGU's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, HLTH has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while HLTH trades at $25.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas HLTH's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to HLTH's ROE of +0.00%. Regarding short-term risk, TDOC is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check HLTH's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CNVY trades at $10.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CNVY's P/E ratio is -71.50. In terms of profitability, TDOC's ROE is -0.12%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, TDOC is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CNVY's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while NAVA trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas NAVA's P/E ratio is N/A. In terms of profitability, TDOC's ROE is -0.12%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, TDOC is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for TDOC.Check NAVA's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CERN has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CERN trades at $94.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CERN's P/E ratio is 55.84. In terms of profitability, TDOC's ROE is -0.12%, compared to CERN's ROE of +0.14%. Regarding short-term risk, TDOC is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CERN's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while CSLT trades at $2.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas CSLT's P/E ratio is -37.27. In terms of profitability, TDOC's ROE is -0.12%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, TDOC is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for TDOC.Check CSLT's competition here

Teladoc Health, Inc. (NYSE: TDOC) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TDOC stands at 1.8B. In comparison, NH has a market cap of 0. Regarding current trading prices, TDOC is priced at $9.71 on the NYSE, while NH trades at $1.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TDOC currently has a P/E ratio of -10.79, whereas NH's P/E ratio is -0.12. In terms of profitability, TDOC's ROE is -0.12%, compared to NH's ROE of +0.35%. Regarding short-term risk, TDOC is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for TDOC.Check NH's competition here